The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 77.82%.However, over the last six months, we can see a weaker performance of 206.35%. Over the last 30 days, the price of DYN has leaped by -14.06%. And in the last five days, it has fallen by -13.62%.
Dyne Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $30.27 on 03/01/24 and the lowest value was $6.40 on 10/30/23.
52-week price history of DYN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dyne Therapeutics Inc’s current trading price is -21.87% away from its 52-week high, while its distance from the 52-week low is 269.53%. The stock’s price range during this period has varied between$6.40 and $30.27. The Dyne Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.98 million for the day, a figure considerably lower than their average daily volume of 1.41 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dyne Therapeutics Inc (DYN) has experienced a quarterly rise of 45.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.92B and boasts a workforce of 141 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.44, with a change in price of +13.13. Similarly, Dyne Therapeutics Inc recorded 1,706,596 in trading volume during the last 100 days, posting a change of +124.81%.
DYN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DYN stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.25.
DYN Stock Stochastic Average
Dyne Therapeutics Inc’s raw stochastic average for the past 50 days is presently 26.77%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 1.76%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.03% and 21.17%, respectively.
